Altair raises $17 million

Altair Therapeutics Inc. (San Diego, Calif.) raised $17 million in a series A round led by new investor Domain Associates. AgeChem Venture Fund, also a new investor, joined existing investors Thomas, McNerney; Forward Ventures; and Isis Pharmaceuticals Inc. (NASDAQ:ISIS). ...